Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of laser-assisted cisplatin + 5-fluorouracil for basal cell carcinoma
2018-000141-39Phase 2Completed
- Sponsor
- Merete Hædersdal
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and fluorouracil in basal cell carcinoma (BCC), sponsored by Merete Hædersdal. Primary endpoint: Tolerability. Started Jan 2018; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2018-000141-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000141-39.